MCVT Among Core Aggregate ETFs
End-of-day Nov 18, 2026 · 82 Core aggregate ETFs by YTD
Bridgebio Pharma, Inc. 1.75%, Due 03/01/2031 3.6%Merit Medical Systems, Inc. 3%, Due 02/01/2029 3.1%Uber Technologies, Inc. 0.875%, Due 12/01/2028 3.0%Mirion Technologies, Inc. 0.25%, Due 06/01/2030 3.0%
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.9% | −2.8% | −1.9% | −7.1% | — | — | — | — | — | +5.4% |
| Peer average | +0.2% | −0.4% | +0.4% | −1.2% | −0.9% | −0.3% | +15.9% | +2.3% | +18.7% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$36 of every $1,000 in MCVT is Bridgebio
| # | |||||
|---|---|---|---|---|---|
| 1 | —Bridgebio Pharma, 1.75%, Due 03/01/2031 | 3.64% | $363.90 | 650K | $1.1M |
| 2 | —Merit Medical Systems, 3%, Due 02/01/2029 | 3.06% | $305.93 | 800K | $920K |
| 3 | —Uber Technologies, 0.875%, Due 12/01/2028 | 3.03% | $302.85 | 800K | $911K |
| 4 | —Mirion Technologies, 0.25%, Due 06/01/2030 | 3.00% | $299.81 | 900K | $902K |
| 5 | —Ormat Technologies, 2.5%, Due 07/15/2027 | 2.93% | $293.14 | 800K | $881K |
| 6 | —TransMedics Group, 1.5%, Due 06/01/2028 | 2.91% | $291.29 | 700K | $876K |
| 7 | —Nova 0%, Due 09/15/2030 | 2.78% | $278.36 | 700K | $837K |
| 8 | —Etsy, 1%, Due 06/15/2030 | 2.77% | $277.46 | 700K | $834K |
| 9 | —Dropbox, 0%, Due 03/01/2028 | 2.75% | $274.62 | 750K | $826K |
| 10 | —Granite Construction, 3.25%, Due 06/15/2030 | 2.72% | $272.00 | 500K | $818K |
| 11 | —Tetra Tech, 2.25%, Due 08/15/2028 | 2.66% | $265.70 | 700K | $799K |
| 12 | —HAT I, LLC / HAT II, LLC 3.75%, Due 08/15/2028 | 2.64% | $264.02 | 550K | $794K |
| 13 | —Haemonetics 2.5%, Due 06/01/2029 | 2.64% | $263.81 | 650K | $793K |
| 14 | —Bloom Energy 0%, Due 11/15/2030 | 2.60% | $260.17 | 650K | $782K |
| 15 | —Revolution Medicines, 0.5%, Due 05/01/2033 | 2.59% | $258.99 | 700K | $779K |
Not enough history yet: MCVT needs a year of prices.
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 21, 2026 | $0.0236 |
| Jun 15, 2026 | Jun 22, 2026 | $0.0075 |
of the $592B in 91 Core aggregate ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | — | Bridgebio Pharma, 1.75%, Due 03/01/2031 | 3.64% |
| 2 | — | Merit Medical Systems, 3%, Due 02/01/2029 | 3.06% |
| 3 | — | Uber Technologies, 0.875%, Due 12/01/2028 | 3.03% |
| 4 | — | Mirion Technologies, 0.25%, Due 06/01/2030 | 3.00% |
| 5 | — | Ormat Technologies, 2.5%, Due 07/15/2027 | 2.93% |
| 6 | — | TransMedics Group, 1.5%, Due 06/01/2028 | 2.91% |
| 7 | — | Nova 0%, Due 09/15/2030 | 2.78% |
| 8 | — | Etsy, 1%, Due 06/15/2030 | 2.77% |
| 9 | — | Dropbox, 0%, Due 03/01/2028 | 2.75% |
| 10 | — | Granite Construction, 3.25%, Due 06/15/2030 | 2.72% |